Cell and Gene Therapy Sector Sees 30% Investment Surge Despite Market Challenges

Industry updates and investment insights—including investor behavior and fundraising advice—were among the topics experts explored at Charles River Laboratories’ 2025 Cell & Gene Therapy Summit.